ANIK Live signals | Maximize Profits with Getagraph.com

Live Chart Being Loaded With Signals

Commentary (1 Jul 2024 @ 16:00):
Our systems believe the stock currently is overvalued by 0.00% compare to its pairs and should correct downwards.

Stats
Today's Volume	38 033
Average Volume	57 466
Market Cap	384.06M
EPS	$-0.310 ( Q1 \| 2024-05-08 )
Next earnings date	( $0 ) 2024-08-06
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-4.93 (Sector) 42.63 (Industry) 0
ATR14	$0.0410 (0.16%)

AEMD -9.77%

AFIB -12.68%

AHCO -2.70%

AHPI 0.00%

ALGN -1.16%

ANIK 2.05%

APEN 0.00%

APYX -2.99%

ARAY -3.30%

ATEC -4.50%

AXDX 0.00%

AXGN 6.49%

AXNX 0.10%

AZYO 2.05%

BBLG -2.44%

BIOL 7.80%

BJDX 0.87%

BMRA 0.07%

BRKR -2.32%

BSGM -0.06%

BWAY -3.46%

CERS -2.27%

CFMS 0.44%

CLPT -1.11%

CODX 0.80%

CSII 0.15%

CTKB 0.54%

CTSO -0.43%

CUTR -0.66%

CVRX -2.34%

DCTH -1.31%

DXCM -1.07%

DYNT -16.23%

EAR -4.10%

ECOR 0.00%

EDAP -4.04%

ESTA -4.62%

FONR 0.88%

HJLI -1.98%

HSDT -1.15%

HSKA 0.00%

HYPR 8.07%

IART -0.58%

ICAD -2.69%

ICCM -0.68%

IINN -11.59%

INGN -3.69%

INMD -2.03%

IRIX -3.24%

IRMD -1.14%

IRTC -1.11%

ISO 0.00%

ITMR 0.00%

KIDS -1.91%

LHDX 0.00%

LIVN -0.62%

LNSR -1.22%

LUCD -3.78%

LUNG -1.58%

MASS -7.38%

MDGS 10.28%

MOTS -16.81%

MOVE 5.78%

MSON 0.00%

NAOV -0.10%

NARI 4.24%

NMRD 33.33%

NNOX -2.59%

NPCE -3.17%

NTUS 0.00%

NURO -1.62%

NUVA -2.24%

NUWE -3.18%

NVCN 0.00%

NVNO -2.48%

OBLN -5.86%

OFIX -2.87%

OM -4.16%

PACB -12.41%

PAVM -6.26%

PETV -23.08%

PODD -2.79%

PRCT 1.28%

PROF 2.01%

QIPT -1.24%

QTRX -4.01%

RCEL -2.53%

RPID 3.05%

RSLS 3.86%

RWLK 6.07%

RXST -5.60%

SGHT -5.40%

SIBN -0.23%

SIEN -18.69%

SILK -0.33%

SINT -5.21%

SOLY 0.00%

SRDX -0.33%

SRGA 0.00%

SRTS -6.47%

SWAV 0.00%

TBIO 5.75%

TCMD -4.44%

TELA -4.47%

THMO -16.67%

TIVC -1.19%

TLIS -4.20%

TMCI -2.41%

TMDI 0.00%

TMDX -0.29%

TNDM -2.08%

TNON 18.05%

UFPT 9.56%

VERO -8.17%

VIVE 0.00%

VMD -2.29%

VRAY 0.00%

VREX -2.99%

VVOS 6.31%

XAIR 18.39%

XENT 0.00%

ZIMV -0.66%

Insider Trading

Date	Person	Action	Amount	type
2024-06-03	Jellison William R	Buy	468	Common Stock
2024-06-03	Griffin Stephen D.	Buy	96 525	Stock Option (Right to Buy)
2024-06-03	Griffin Stephen D.	Buy	38 520	Restricted Stock Unit
2024-06-03	Capper Joseph H	Buy	468	Common Stock
2024-05-28	Jellison William R	Sell	0	Common Stock

INSIDER POWER
58.22
Last 100 transactions
Buy: 1 137 227 \| Sell: 334 525

Correlation (AI algo v.1.1b): Overvalued: 0.00% $25.85 paired level. (The Algo Track The Changes Of The Most Correlated Stocks In Realtime And Give An Instant Update)

Volume Correlation

Long: -0.46 (neutral)

Short: -0.89 (strong negative)

Signal:(52.7) Neutral

Anika Therapeutics Inc Correlation

10 Most Positive Correlations
OZEM	1
AAIDX	0.901
DMAT	0.9
ICOP	0.89
COPP	0.887
SETM	0.886
BRKHW	0.875
MSAQX	0.871
PTSHX	0.87
FFGCX	0.868

10 Most Negative Correlations
APPS	-0.881
IMKTA	-0.879
PETS	-0.879
TBLT	-0.878
ALNY	-0.874
TWOU	-0.874
WBD	-0.873
UTMD	-0.872
BMRC	-0.87
EMBC	-0.87

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Anika Therapeutics Inc Correlation - Currency/Commodity

-0.46
( neutral )

0.27
( neutral )

0.00
( neutral )

-0.48
( neutral )

0.64
( weak )

0.22
( neutral )

Anika Therapeutics Inc Financials

Annual	2023
Revenue:	$166.66M
Gross Profit:	$103.09M (61.85 %)
EPS:	$-5.64

FY	2023
Revenue:	$166.66M
Gross Profit:	$103.09M (61.85 %)
EPS:	$-5.64

FY	2022
Revenue:	$156.24M
Gross Profit:	$93.58M (59.89 %)
EPS:	$-1.020

FY	2021
Revenue:	$147.79M
Gross Profit:	$82.94M (56.12 %)
EPS:	$0.290

Financial Reports:

No articles found.

Anika Therapeutics Inc Options Data

Calls

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

Puts

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

Anika Therapeutics Inc

Anika Therapeutics, Inc., a joint preservation company, creates and delivers advancements in early intervention orthopedic care in the areas of osteoarthritis (OA) pain management, regenerative solutions, soft tissue repair, and bone preserving joint technologies in the United States, Europe, and internationally. The company develops, manufactures, and commercializes products based on hyaluronic acid (HA) technology platform. Its OA pain management product family consists of Monovisc, Orthovisc, Cingal, and Hyvisc that are indicated to provide pain relief from osteoarthritis conditions; and joint preservation and restoration product family comprise a portfolio of approximately 150 bone preserving joint technology products, a line of sports medicine soft tissue repair solutions, and orthopedic regenerative solutions products. The company's non-orthopedic product family include HA-based products for non-orthopedic applications, including adhesion barrier products, advanced wound care products, ophthalmic products, and ear, nose, and throat products. Anika Therapeutics, Inc. was founded in 1983 and is headquartered in Bedford, Massachusetts.